Avoiding Cross-Contamination in Antibiotic Manufacturing, the FDA Way

Source: PharmaManufacturing.com

Apr 24, 2013

in-Pharma Technologist

Both penicillin and non-penicillin beta-lactam drugs can initiate drug-induced hypersensitivity reactions in some patients which can be life-threatening. Therefore the US Food and Drug Administration (FDA) has issued a series of recommendations to antibiotic manufacturers in order to minimise the risk of cross-contamination at plants that produce multiple products. Read the full story. 
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments